Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...
Eli Lilly plans to launch its diabetes and weight-loss drug, Mounjaro, in emerging markets such as India, Brazil, and Mexico in 2025. The expansion leverages growing demand in populous countries ...
(Reuters) - Eli Lilly plans to launch its blockbuster diabetes ... Outside the U.S., the company has plants in Ireland, Italy and Spain. Lilly has forecast total sales to be between $58 billion ...
ECIM 2025 saw a heated discussion on whether anticoagulation in DVT should be treated like a chronic condition, as new ...
President Trump threatened to impose a 200% tariff on EU wines and champagne unless the EU rescinds its 50% tax on US alcohol ...
Pharmaceutical Technology on MSN2d
Viking strikes $150m deal to secure supply of obesity drugViking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...
Pharmaceutical Technology on MSN2d
Zealand and Roche strike $5.3bn obesity treatment dealThe two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.
PT: Why do you think Eli Lilly is coming out as a social media ... focused on six countries [US, Germany, France, Italy, UK and Japan]. The communities are smaller here, deliberately so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback